Ascendis Pharma A (ASND) Depreciation & Amortization (CF) (2014 - 2026)
Ascendis Pharma A (ASND) reported Depreciation & Amortization (CF) of $5.31 million for the quarter ended Jun 30, 2026, up 8.9% from $4.88 million a year earlier and up 7.5% from the prior quarter.
Powered by 
Analysis
Ascendis Pharma A (ASND) Depreciation & Amortization (CF) (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Ascendis Pharma A's Depreciation & Amortization (CF) came in at $19.99 million, up 5.3% year-over-year; for the year ended Dec 31, 2025, it came in at -$86.34 million.
- By year, Depreciation & Amortization (CF) came in at -$91.62 million in the year ended Dec 31, 2024, -$77.36 million in the year ended Dec 31, 2023, $18.46 million in the year ended Dec 31, 2022 (+8.0%) and $17.1 million in the year ended Dec 31, 2021 (+51.8%).
- Five-year quarterly Depreciation & Amortization (CF) spans a low of $4.28 million in the quarter ended Sep 30, 2025 and a high of $5.47 million in the quarter ended Dec 31, 2025.
- Year over year, Depreciation & Amortization (CF) has now increased in each of the last three quarters, with growth averaging 1.3% over the last eight quarters.
- The high point for year-over-year Depreciation & Amortization (CF) in five years was the quarter ended Sep 30, 2021 (growth of 63.3%); the low point was the quarter ended Dec 31, 2024 (a decline of 10.4%).
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $4.94 million (quarter ended Mar 31, 2026), $5.47 million (quarter ended Dec 31, 2025) and $4.28 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.96 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 194.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 599.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.93 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 98.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.62 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 56.50 Mn |
| 10 | Ascendis Pharma A | 14.12 Bn | 10.37 Bn | 362.22 Mn | 5.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.31 Mn |
| Mar 31, 2026 | 4.94 Mn |
| Dec 31, 2025 | 5.47 Mn |
| Sep 30, 2025 | 4.28 Mn |
| Jun 30, 2025 | 4.88 Mn |
| Mar 31, 2025 | 4.78 Mn |
| Dec 31, 2024 | 4.65 Mn |
| Sep 30, 2024 | 4.68 Mn |
| Jun 30, 2024 | 4.60 Mn |
| Mar 31, 2024 | 4.74 Mn |
| Dec 31, 2023 | 5.19 Mn |
| Sep 30, 2023 | 5.04 Mn |
| Jun 30, 2023 | 4.94 Mn |
| Mar 31, 2023 | 4.76 Mn |
| Dec 31, 2022 | 4.62 Mn |
| Sep 30, 2022 | 4.44 Mn |
| Jun 30, 2022 | 4.57 Mn |
| Mar 31, 2022 | 4.83 Mn |
| Dec 31, 2021 | 4.76 Mn |
| Sep 30, 2021 | 4.33 Mn |
API Access
Ascendis Pharma A Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();